GlassScriptPhysician profile
Katy Finney
NPI 1538545660
$7,342.10
in general payments reported to CMS, 2019-2025
20 companies · $2,521 in 2025
The $2,521 reported for 2025 was more than what 96% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $184 · 2022: $976 · 2023: $944 · 2024: $2,717 · 2025: $2,521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,408 · Travel and Lodging: $1,694 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,407.99 |
| Travel and Lodging | $1,694.24 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,864.50 | 2024-2025 | Cardiomems, Aveir |
| Boston Scientific Corporation | $1,253.99 | 2023-2025 | Watchman Access System, Bodyguardian, Watchman Flx |
| Amgen INC. | $1,218.87 | 2021-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $579.74 | 2022-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $417.80 | 2022-2025 | |
| Actelion Pharmaceuticals US, INC. | $349.51 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Janssen Pharmaceuticals, INC | $301.59 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $248.77 | 2022 | |
| Merck Sharp & Dohme LLC | $204.64 | 2022-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $199.09 | 2021-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $193.85 | 2023-2025 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $152.89 | 2025 | |
| Pfizer INC. | $140.71 | 2023-2025 | |
| Scpharmaceuticals INC. | $52.19 | 2025 | |
| Ethicon US, LLC | $51.69 | 2023-2025 | Ethicon, Vistaseal, Smartablatetm System Rf Generator |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $33.49 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
| Novo Nordisk INC | $20.12 | 2025 | Wegovy |
| Abbvie INC. | $20.02 | 2024 | |
| Axonics, INC. | $19.39 | 2024 | Axonics |
| Irhythm Technologies, INC. | $19.25 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katy Finney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.